Syneos Health Valuation
| SYNHDelisted Stock | USD 42.31 0.07 0.17% |
At this time, the company appears to be overvalued. Syneos Health has a current Real Value of $35.03 per share. The regular price of the company is $42.31. Our model measures the value of Syneos Health from inspecting the company fundamentals such as Operating Margin of 0.06 %, shares outstanding of 103.72 M, and Return On Equity of 0.0209 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Syneos Health's price fluctuation is very steady at this time. Calculation of the real value of Syneos Health is based on 3 months time horizon. Increasing Syneos Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Syneos Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Syneos Stock. However, Syneos Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 42.31 | Real 35.03 | Hype 42.31 | Naive 41.93 |
The intrinsic value of Syneos Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Syneos Health's stock price.
Estimating the potential upside or downside of Syneos Health helps investors to forecast how Syneos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Syneos Health more accurately as focusing exclusively on Syneos Health's fundamentals will not take into account other important factors: Syneos Health Total Value Analysis
Syneos Health is at this time estimated to have valuation of 7.23 B with market capitalization of 4.43 B, debt of 2.9 B, and cash on hands of 124.2 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Syneos Health fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.23 B | 4.43 B | 2.9 B | 124.2 M |
Syneos Health Investor Information
About 95.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Syneos Health has Price/Earnings To Growth (PEG) ratio of 1.28. The entity had not issued any dividends in recent years. Based on the key indicators obtained from Syneos Health's historical financial statements, Syneos Health is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Syneos Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Syneos Health has an asset utilization ratio of 65.78 percent. This signifies that the Company is making $0.66 for each dollar of assets. An increasing asset utilization means that Syneos Health is more efficient with each dollar of assets it utilizes for everyday operations.Syneos Health Ownership Allocation
Syneos Health shows a total of 103.72 Million outstanding shares. The majority of Syneos Health outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Syneos Health to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Syneos Health. Please pay attention to any change in the institutional holdings of Syneos Health as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Syneos Health Profitability Analysis
The company reported the previous year's revenue of 5.39 B. Net Income was 266.5 M with profit before overhead, payroll, taxes, and interest of 1.25 B.About Syneos Health Valuation
An absolute valuation paradigm, as applied to Syneos Stock, attempts to find the value of Syneos Health based on its fundamental and basic technical indicators. By analyzing Syneos Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Syneos Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Syneos Health. We calculate exposure to Syneos Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Syneos Health's related companies.Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Syneos Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 26751 people.
Syneos Health Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 103.5 M | |
| Quarterly Earnings Growth Y O Y | -0.99 | |
| Forward Price Earnings | 8.0128 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |